Sites protection for 3 vaccines and drug production sites

Context and challenges

This client, leader in the pharmaceutical industry, is dedicated to the discovery and the production of prophylactic and therapeutic vaccines. It has 3 production sites which constitute one of the largest industrial clusters of vaccines production in Europe.

Their objective is to ensure compliance with safety standards of all sensitive areas of buildings producing vaccines and medicines with highly protected patents.

The project aims to secure every site according to 7 major tasks:

Revamping of access control system
Revamping of video surveillance
Set up of intrusion detection
Set up of videophone system
Set up of Security Control Room
Set up of X-ray machine and Bomb basket (containment device)
Set up of waste secure storage

GSK appointed Assystem for a EPCm engagement for the securing of its sites in Belgium.

Project scope

Co-development of the definition of access control requirements for all sites
Project management services, including following 3 phases:
Basic Design
Detailed Design, including assistance with the execution of construction contracts
Monitoring of services and works (construction, commissioning and hand-over)

Results

Set up of more than 2,500 accesses and installation of more than 400 mobile and fixed cameras, spread over 65 buildings
Set up of more than 200 equipments for perimeter intrusion detection (thermal imaging cameras and infrared devices)
No production disruption (15 buildings equipped during the shut down period)
Access management improvement thanks to innovative technologies: a single badge for all buildings, implementation of authorizations by zone and standard profiles, centralized access management (staff, subcontractors, visitors)